These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Generation of bispecific and tandem diabodies. Kipriyanov SM Methods Mol Biol; 2009; 562():177-93. PubMed ID: 19554296 [TBL] [Abstract][Full Text] [Related]
64. Construction and structural modeling of a single-chain Fv-asparaginase fusion protein resistant to proteolysis. Guo L; Wang J; Qian S; Yan X; Chen R; Meng G Biotechnol Bioeng; 2000 Nov; 70(4):456-63. PubMed ID: 11005928 [TBL] [Abstract][Full Text] [Related]
65. Intrabody construction and expression III: engineering hyperstable V(H) domains. Wirtz P; Steipe B Protein Sci; 1999 Nov; 8(11):2245-50. PubMed ID: 10595527 [TBL] [Abstract][Full Text] [Related]
66. Conserved amino acid networks involved in antibody variable domain interactions. Wang N; Smith WF; Miller BR; Aivazian D; Lugovskoy AA; Reff ME; Glaser SM; Croner LJ; Demarest SJ Proteins; 2009 Jul; 76(1):99-114. PubMed ID: 19089973 [TBL] [Abstract][Full Text] [Related]
67. Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule. Friedman M; Lindström S; Ekerljung L; Andersson-Svahn H; Carlsson J; Brismar H; Gedda L; Frejd FY; Ståhl S Biotechnol Appl Biochem; 2009 Aug; 54(2):121-31. PubMed ID: 19492986 [TBL] [Abstract][Full Text] [Related]
68. A new format of bispecific antibody: highly efficient heterodimerization, expression and tumor cell lysis. Xie Z; Guo N; Yu M; Hu M; Shen B J Immunol Methods; 2005 Jan; 296(1-2):95-101. PubMed ID: 15680154 [TBL] [Abstract][Full Text] [Related]
69. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display. Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188 [TBL] [Abstract][Full Text] [Related]
70. [Construction and expression of single chain Fv antibody against human bladder carcinoma]. Zhang M; Yu L; Huang H Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):792-5. PubMed ID: 16201198 [TBL] [Abstract][Full Text] [Related]
71. [Construction of human phage-displayed scFv library and selection of the ScFv against rabies virus]. Zhao XL; Yin J; Wang H; Jiang M; Hou XJ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):243-7. PubMed ID: 15191736 [TBL] [Abstract][Full Text] [Related]
73. High level prokaryotic expression of anti-Müllerian inhibiting substance type II receptor diabody, a new recombinant antibody for in vivo ovarian cancer imaging. Ortega C; Herbet A; Richard S; Kersual N; Costa N; Pèlegrin A; Ducancel F; Couraud JY; Navarro-Teulon I; Boquet D J Immunol Methods; 2013 Jan; 387(1-2):11-20. PubMed ID: 22910001 [TBL] [Abstract][Full Text] [Related]
74. Improving solubility and refolding efficiency of human V(H)s by a novel mutational approach. Tanha J; Nguyen TD; Ng A; Ryan S; Ni F; Mackenzie R Protein Eng Des Sel; 2006 Nov; 19(11):503-9. PubMed ID: 16971398 [TBL] [Abstract][Full Text] [Related]
75. [Construction and expression of single chain variable fragments (ScFv) against human CD19 antigen]. Chen S; Rao Q; Wang JX; Wang M Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):686-91. PubMed ID: 16285505 [TBL] [Abstract][Full Text] [Related]
77. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains. Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019 [TBL] [Abstract][Full Text] [Related]
78. Functional characterization of an anti-estradiol antibody by site-directed mutagenesis and molecular modelling: modulation of binding properties and prominent role of the V(L) domain in estradiol recognition. Coulon S; Pellequer JL; Blachère T; Chartier M; Mappus E; Chen Sw SW; Cuilleron CY; Baty D J Mol Recognit; 2002; 15(1):6-18. PubMed ID: 11870917 [TBL] [Abstract][Full Text] [Related]
79. Improvement in soluble expression levels of a diabody by exchanging expression vectors. Liu F; Chen Z; Jiang W; Yang C; Xiong D; Zhu Z Protein Expr Purif; 2008 Nov; 62(1):15-20. PubMed ID: 18667166 [TBL] [Abstract][Full Text] [Related]
80. A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity. Lu D; Zhang H; Koo H; Tonra J; Balderes P; Prewett M; Corcoran E; Mangalampalli V; Bassi R; Anselma D; Patel D; Kang X; Ludwig DL; Hicklin DJ; Bohlen P; Witte L; Zhu Z J Biol Chem; 2005 May; 280(20):19665-72. PubMed ID: 15757893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]